| Tumor suppressor p53 mediates apoptotic cell death triggered by cyclosporin A | None |
| Tumor suppressor p53 mediates apoptotic cell death triggered by cyclosporin A. | None |
| Human tumor suppressor ARF impedes S-phase progression independent of p53. | None |
| NO induces the accumulation of transcriptionally active p53 in a variety of cell types and NO signaling to p53 does not require ataxia telangiectasia-mutated (ATM), poly(ADP-ribose) polymerase 1, or the ARF tumor suppressor protein | None |
| Refolding and structural characterization of the human p53 tumor suppressor protein. | None |
| Redox state of tumor suppressor p53 regulates its sequence-specific DNA binding in DNA-damaged cells by cysteine 277. | None |
| Characterization of the promoter region of UPase has indicated a direct regulation of its expression by the tumor suppressor gene p53. Review. | None |
| Data suggest a model in which p53 directly recruits a TRRAP/acetyltransferase complex to the mdm2 gene to activate transcription. In addition, this study defines a novel mechanism utilized by the p53 tumor suppressor to regulate gene expression. | None |
| Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner. | None |
| The suppression of STK15 oncogenic activity by p53 might be explained by the finding that p53 inhibited STK15 kinase activity via direct interaction with the latter_s Aurora box. This revealed a novel mechanism for the tumor suppressor function of p53. | None |
| The candidate tumor suppressor ING1b can stabilize p53 by disrupting the regulation of p53 by MDM2. | None |
| Purification, crystallization and preliminary X-ray analysis of the BRCT domains of human 53BP1 bound to the p53 tumour suppressor | None |
| azurin, tumor suppressor protein p53, and regression of cancer | None |
| IRF-1 and the tumour suppressor protein p53 are coordinately up-regulated during the response to DNA damage in an ATM-dependent manner. | None |
| investigated whether Tat might alter p53 acetylation and p53-responsive transcription; results allude to mechanism where the HIV-1 trans-activator might impair tumor suppressor functions favoring establishment of neoplasia in AIDS | None |
| The complement inhibitor CD59 and the lymphocyte function-associated antigen-3 (LFA-3, CD58) genes possess functional binding sites for the p53 tumor suppressor protein. | None |
| cyclin G1 has growth inhibitory activity that is mechanistically linked to ARF-p53 and pRb tumor suppressor pathways. | None |
| Methylation of CpG and CCWGG motifs in the promoter of TP53 could represent a novel mechanism leading to functional impairment of this tumor suppressor gene in ALL. | None |
| EGR1 as a major regulator of cell senescence and previously undescribed upstream gatekeeper of the p53 tumor suppressor pathway. | None |
| deacetylase HDAC1 acts as an antagonist of the tumor suppressor p53 in the regulation of the cyclin-dependent kinase inhibitor p21 | None |